IBM®
Skip to main content
    Country/region [change]    Terms of use
 
 
 
    Home    Products    Services & solutions    Support & downloads    My account    

IBM Journal of Research and Development
Systems Biology   Volume 50, Number 6, 2006
Table of contents: HTMLPDF This article: HTMLPDF   Copyright info

Multiscale biosystems integration: Coupling intracellular network analysis with tissue-patterning simulations - References

 by S. M. Peirce,
T. C. Skalak,
and J. A. Papin
References

  1. A. Bernal, U. Ear, and N. Kyrpides, “Genomes OnLine Database (GOLD): A Monitor of Genome Projects World-Wide,” Nucl. Acids Res. 29, No. 1, 126–127 (2001).
  2. T. Barrett, T. O. Suzek, D. B. Troup, S. E. Wilhite, W. C. Ngau, P. Ledoux, D. Rudnev, A. E. Lash, W. Fujibuchi, and R. Edgar, “NCBI GEO: Mining Millions of Expression Profiles—Database and Tools,” Nucl. Acids Res. 33, D562–D566 (2005).
  3. H. Ge, A. J. Walhout, and M. Vidal, “Integrating ‘Omic’ Information: A Bridge Between Genomics and Systems Biology,” Trends Genet. 19, No. 10, 551–560 (2003).
  4. B. Palsson, “In Silico Biology Through ‘Omics,’ ”, Nat. Biotechnol. 20, No. 7, 649–650 (2002).
  5. J. S. Edwards and B. O. Palsson, “Systems Properties of the Haemophilus Influenzae Rd Metabolic Genotype,” J. Biol. Chem. 274, No. 25, 17410–17416 (1999).
  6. F. Jacob and J. Monod, “Genetic Regulatory Mechanisms in the Synthesis of Proteins,” J. Mol. Biol. 3, 318–356 (1961).
  7. E. H. Davidson, J. P. Rast, P. Oliveri, A. Ransick, C. Calestani, C. H. Yuh, T. Minokawa, G. Amore, V. Hinman, C. Arenas-Mena, O. Otim, C. T. Brown, C. B. Livi, P. Y. Lee, R. Revilla, A. G. Rust, Z. Pan, M. J. Schilstra, P. J. Clarke, M. I. Arnone, L. Rowen, R. A. Cameron, D. R. McClay, L. Hood, and H. Bolouri, “A Genomic Regulatory Network for Development,” Science 295, No. 5560, 1669–1678 (2002).
  8. J. A. Papin, T. Hunter, B. O. Palsson, and S. Subramaniam, “Reconstruction of Cellular Signaling Networks and Analysis of Their Properties,” Nat. Rev. Mol. Cell Biol. 6, No. 2, 99–111 (2005).
  9. I. Borodina and J. Nielsen, “From Genomes to In Silico Cells via Metabolic Networks,” Curr. Opin. Biotechnol. 16, No. 3, 350–355 (2005).
  10. K. Sachs, O. Perez, D. Pe’er, D. A. Lauffenburger, and G. P. Nolan, “Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data,” Science 308, No. 5721, 523–529 (2005).
  11. F. Starling, “On the Absorption of Fluids from the Connective Tissue Spaces,” J. Physiol. 19, 312–326 (1896).
  12. A. Krogh, The Anatomy and Physiology of Capillaries, Yale University Press, New Haven, CT, 1930.
  13. R. L. Gleason and J. D. Humphrey, “A Mixture Model of Arterial Growth and Remodeling in Hypertension: Altered Muscle Tone and Tissue Turnover,” J. Vasc. Res. 41, No. 4, 352–363 (2004).
  14. R. J. Price, J. R. Less, E. J. Van Gieson, and T. C. Skalak, “Hemodynamic Stresses and Structural Remodeling of Anastomosing Arteriolar Networks: Design Principles of Collateral Arterioles,” Microcirculation 9, No. 2, 111–124 (2002).
  15. A. R. Pries and T. W. Secomb, “Control of Blood Vessel Structure: Insights from Theoretical Models,” Amer. J. Physiol. Heart Circ. Physiol. 288, No. 3, H1010–H1015 (2005).
  16. A. L. Hodgkin and A. F. Huxley, “A Quantitative Description of Membrane Current and Its Application to Conduction and Excitation in Nerve,” J. Physiol. 117, No. 4, 500–544 (1952).
  17. A. Destexhe and E. Marder, “Plasticity in Single Neuron and Circuit Computations,” Nature 431, No. 7010, 789–795 (2004).
  18. A. K. Chakraborty, M. L. Dustin, and A. S. Shaw, “In Silico Models for Cellular and Molecular Immunology: Successes, Promises and Challenges,” Nat. Immunol. 4, No. 10, 933–936 (2003).
  19. J. W. Kim and C. V. Dang, “Multifaceted Roles of Glycolytic Enzymes,” Trends Biochem. Sci. 30, No. 3, 142–150 (2005).
  20. N. D. Price, J. L. Reed, and B. O. Palsson, “Genome-Scale Models of Microbial Cells: Evaluating the Consequences of Constraints,” Nat. Rev. Microbiol. 2, No. 11, 886–897 (2004).
  21. J. L. Reed and B. O. Palsson, “Thirteen Years of Building Constraint-Based In Silico Models of Escherichia coli,” J. Bacteriol. 185, No. 9, 2692–2699 (2003).
  22. B. M. Bakker, P. A. Michels, F. R. Opperdoes, and H. V. Westerhoff, “What Controls Glycolysis in Bloodstream Form Trypanosoma brucei?”, J. Biol. Chem. 274, No. 21, 14551–14559 (1999).
  23. M. W. Covert, E. M. Knight, J. L. Reed, M. J. Herrgard, and B. O. Palsson, “Integrating High-Throughput and Computational Data Elucidates Bacterial Networks,” Nature 429, No. 6987, 92–96 (2004).
  24. B. Schoeberl, C. Eichler-Jonsson, E. D. Gilles, and G. Muller, “Computational Modeling of the Dynamics of the MAP Kinase Cascade Activated by Surface and Internalized EGF Receptors,” Nat. Biotechnol. 20, No. 4, 370–375 (2002).
  25. H. S. Wiley, S. Y. Shvartsman, and D. A. Lauffenburger, “Computational Modeling of the EGF-Receptor System: A Paradigm for Systems Biology,” Trends Cell Biol. 13, No. 1, 43–50 (2003).
  26. J. A. Papin and B. O. Palsson, “The JAK–STAT Signaling Network in the Human B-Cell: An Extreme Signaling Pathway Analysis,” Biophys. J. 87, No. 1, 37–46 (2004).
  27. M. Steffen, A. Petti, J. Aach, P. D’Haeseleer, and G. Church, “Automated Modelling of Signal Transduction Networks,” BMC Bioinformatics 3, No. 1, 34 (2002).
  28. M. W. Covert, C. H. Schilling, I. Famili, J. S. Edwards, I. Goryanin, E. Selkov, and B. O. Palsson, “Metabolic Modeling of Microbial Strains In Silico,” Trends Biochem. Sci. 26, No. 3, 179–186 (2001).
  29. K. J. Kauffman, P. Prakash, and J. S. Edwards, “Advances in Flux Balance Analysis,” Curr. Opin. Biotechnol. 14, No. 5, 491–496 (2003).
  30. D. Segre, D. Vitkup, and G. M. Church, “Analysis of Optimality in Natural and Perturbed Metabolic Networks,” Proc. Natl. Acad. Sci. U.S.A. 99, No. 23, 15112–15117 (2002).
  31. D. A. Beard, S. D. Liang, and H. Qian, “Energy Balance for Analysis of Complex Metabolic Networks,” Biophys. J. 83, No. 1, 79–86 (2002).
  32. V. Chvatal, Linear Programming, W. H. Freeman & Co., New York, 1983.
  33. J. A. Papin, N. D. Price, S. J. Wiback, D. Fell, and B. O. Palsson, “Metabolic Pathways in the Post-Genome Era,” Trends Biochem. Sci. 28, No. 5, 250–258 (2003).
  34. E. Almaas, B. Kovacs, T. Vicsek, Z. N. Oltvai, and A. L. Barabasi, “Global Organization of Metabolic Fluxes in the Bacterium Escherichia Coli,” Nature 427, No. 6977, 839–843 (2004).
  35. I. Famili, R. Mahadevan, and B. O. Palsson, “k-Cone Analysis: Determining All Candidate Values for Kinetic Parameters on a Network Scale,” Biophys. J. 88, No. 3, 1616–1625 (2005).
  36. J. A. Papin, J. L. Reed, and B. O. Palsson, “Hierarchical Thinking in Network Biology: The Unbiased Modularization of Biochemical Networks,” Trends Biotechnol. 29, No. 12, 641–647 (2004).
  37. A. P. Burgard, E. V. Nikolaev, C. H. Schilling, and C. D. Maranas, “Flux Coupling Analysis of Genome-Scale Metabolic Network Reconstructions,” Genome Res. 14, No. 2, 301–312 (2004).
  38. J. A. Papin, N. D. Price, and B. O. Palsson, “Extreme Pathway Lengths and Reaction Participation in Genome-Scale Metabolic Networks,” Genome Res. 12, No. 12, 1889–1900 (2002).
  39. J. L. Reed and B. O. Palsson, “Genome-Scale In Silico Models of E. coli Have Multiple Equivalent Phenotypic States: Assessment of Correlated Reaction Subsets that Comprise Network States,” Genome Res. 14, No. 9, 1797–1805 (2004).
  40. J. A. Papin, N. D. Price, J. S. Edwards, and B. O. Palsson, “The Genome-Scale Metabolic Extreme Pathway Structure in Haemophilus influenzae Shows Significant Network Redundancy,” J. Theor. Biol. 215, No. 1, 67–82 (2002).
  41. N. D. Price, J. A. Papin, and B. O. Palsson, “Determination of Redundancy and Systems Properties of the Metabolic Network of Helicobacter Pylori Using Genome-Scale Extreme Pathway Analysis,” Genome Res. 12, No. 5, 760–769 (2002).
  42. G. Sirakoulis, I. Karafyllidis, C. Mizas, V. Mardiris, A. Thanailakis, and P. Tsalides, “A Cellular Automaton Model for the Study of DNA Sequence Evolution,” Comput. Biol. Med. 33, No. 5, 439–453 (2003).
  43. H. Zhu, Y. Sun, G. Rajagopal, A. Mondry, and P. Dhar, “Facilitating Arrhythmia Simulation: The Method of Quantitative Cellular Automata Modeling and Parallel Running,” Biomed. Eng. Online 3, No. 29 (2004); see http://www.biomedical-engineering-online.com/content/3/1/29.
  44. Y. Lee, S. Kouvroukoglou, L. V. McIntire, and K. Zygourakis, “A Cellular Automaton Model for the Proliferation of Migrating Contact-Inhibited Cells,” Biophys. J. 69, No. 4, 1284–1298 (1995).
  45. S. Dormann and A. Deutsch, “Modeling of Self-Organized Avascular Tumor Growth with a Hybrid Cellular Automaton,” In Silico Biol. 2, No. 3, 393–406 (2002).
  46. J. L. Segovia-Juarez, S. Ganguli, and D. Kirschner, “Identifying Control Mechanisms of Granuloma Formation During M. tuberculosis Infection Using an Agent-Based Model,” J. Theor. Biol. 231, No. 3, 357–376 (2004).
  47. J. T. Wootton, “Local Interactions Predict Large-Scale Pattern in Empirically Derived Cellular Automata,” Nature 413, No. 6858, 841–844 (2001).
  48. D. Longo, S. M. Peirce, T. C. Skalak, L. Davidson, M. Marsden, B. Dzamba, and D. W. DeSimone, “Multicellular Computer Simulation of Morphogenesis: Blastocoel Roof Thinning and Matrix Assembly in Xenopus laevis,” Dev. Biol. 271, No. 1, 210–222 (2004).
  49. S. M. Peirce, E. J. Van Gieson, and T. C. Skalak, “Multicellular Simulation Predicts Microvascular Patterning and In Silico Tissue Assembly,” FASEB J. 18, No. 6, 731–733 (2004).
  50. K. Zygourakis, R. Bizios, and P. Markenscoff, “Proliferation of Anchorage-Dependent Contact-Inhibited Cells. 1. Development of Theoretical-Models Based on Cellular Automata,” Biotechnol. Bioeng. 38, No. 5, 459–470 (1991).
  51. U. Wilensky, “NetLogo,” Center for Connected Learning and Computer-Based Modeling, Northwestern University, Evanston, IL, 1999; see http://ccl.northwestern.edu/netlogo/.
  52. S. M. Peirce and T. C. Skalak, “Microvascular Remodeling: A Complex Continuum Spanning Angiogenesis to Arteriogenesis,” Microcirculation 10, No. 1, 99–111 (2003).
  53. R. E. Keller, “The Cellular Basis of Epiboly: An SEM Study of Deep-Cell Rearrangement During Gastrulation in Xenopus Laevis,” J. Embryol. Exp. Morphol. 60, 201–234 (1980).
  54. M. Marsden and D. W. DeSimone, “Integrin–ECM Interactions Regulate Cadherin-Dependent Cell Adhesion and Are Required for Convergent Extension in Xenopus,” Curr. Biol. 13, No. 14, 1182–1191 (2003).
  55. D. S. Krause and R. A. Van Etten, “Tyrosine Kinases as Targets for Cancer Therapy,” N. Engl. J. Med. 353, No. 2, 172–187 (2005).
  56. J. Folkman, P. Hahnfeldt, and L. Hlatky, “Cancer: Looking Outside the Genome,” Nat. Rev. Mol. Cell Biol. 1, No. 1, 76–79 (2000).
  57. C. G. Willett, Y. Boucher, E. di Tomaso, D. G. Duda, L. L. Munn, R. T. Tong, D. C. Chung, D. V. Sahani, S. P. Kalva, S. V. Kozin, M. Mino, K. S. Cohen, D. T. Scadden, A. C. Hartford, A. J. Fischman, J. W. Clark, D. P. Ryan, A. X. Zhu, L. S. Blaszkowsky, H. X. Chen, P. C. Shellito, G. Y. Lauwers, and R. K. Jain, “Direct Evidence that the VEGF-Specific Antibody Bevacizumab Has Antivascular Effects in Human Rectal Cancer,” Nat. Med. 10, No. 2, 145–147 (2004).
  58. A. Abdollahi, P. Hahnfeldt, C. Maercker, H. J. Grone, J. Debus, W. Ansorge, J. Folkman, L. Hlatky, and P. E. Huber, “Endostatin's Antiangiogenic Signaling Network,” Mol. Cell 13, No. 5, 649–663 (2004).
  59. P. Alboni, L. Filippi, R. Pirani, A. M. Tomasi, G. C. Candini, and A. Masoni, “Reproducibility of Electrophysiological Parameters of Sinus Node Following Autonomic Blockade,” Int. J. Cardiol. 4, No. 4, 431–442 (1983).
  60. M. R. Bristow, R. Ginsburg, W. Minobe, R. S. Cubicciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. C. Harrison, and E. B. Stinson, “Decreased Catecholamine Sensitivity and Beta-Adrenergic-Receptor Density in Failing Human Hearts,” New England J. Med. 307, No. 4, 205–211 (1982).
  61. F. Waagstein, M. R. Bristow, K. Swedberg, F. Camerini, M. B. Fowler, M. A. Silver, E. M. Gilbert, M. R. Johnson, F. G. Goss, and A. Hjalmarson, “Beneficial Effects of Metoprolol in Idiopathic Dilated Cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group,” Lancet 342, No. 8885, 1441–1446 (1993).
  62. H. Araki, M. Itoh, and K. Nishi, “Effects of Nipradilol on the Microvascular Tone of Rat Mesentery: Comparison with Other Beta-blockers and Vasodilators,” Arch. Int. Pharmacodyn. Ther. 318, 47–54 (1992).
  63. H. N. Sabbah, “The Cellular and Physiologic Effects of Beta Blockers in Heart Failure,” Clin. Cardiol. 22, Suppl. 5, V16–V20 (1999).
  64. N. Toda, “Vasodilating Beta-Adrenoceptor Blockers as Cardiovascular Therapeutics,” Pharmacol. Ther. 100, No. 3, 215–234 (2003).
  65. L. Kalinowski, L. W. Dobrucki, M. Szczepanska-Konkel, M. Jankowski, L. Martyniec, S. Angielski, and T. Malinski, “Third-Generation Beta-Blockers Stimulate Nitric Oxide Release from Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action,” Circulation 107, No. 21, 2747–2752 (2003).
  66. M. W. Covert, I. Famili, and B. O. Palsson, “Identifying Constraints that Govern Cell Behavior: A Key to Converting Conceptual to Computational Models in Biology?”, Biotechnol. Bioeng. 84, No. 7, 763–772 (2003).
  67. G. J. Babu and M. Periasamy, “Transgenic Mouse Models for Cardiac Dysfunction by a Specific Gene Manipulation,” Molecular Cardiology Methods and Protocols, Vol. 112, S. Zhongjie, Ed., Humana Press, Totowa, NJ, 2005, pp. 365–378.
  68. J. P. Gratton, P. Bernatchez, and W. C. Sessa, “Caveolae and Caveolins in the Cardiovascular System,” Circ. Res. 94, No. 11, 1408–1417 (2004).
  69. Y. Huo and K. Ley, “Adhesion Molecules and Atherogenesis,” Acta Physiol. Scand. 173, No. 1, 35–43 (2001).


    About IBM    Privacy    Contact